###begin article-title 0
###xml 37 47 37 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Multiple RNA-protein interactions in Drosophila dosage compensation
###end article-title 0
###begin p 1
###xml 303 313 303 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 14 20 <span type="species:ncbi:9606">humans</span>
From worms to humans, recognizing and modifying a specific chromosome is essential for dosage compensation, the mechanism by which equal X-linked gene expression in males and females is achieved. Recent molecular genetic and biochemical studies have provided new insights into how regulatory factors in Drosophila are recruited and assembled on the X chromosome, leading to the essential hypertranscription of its genes.
###end p 1
###begin title 2
Distinct mechanisms of dosage compensation
###end title 2
###begin p 3
###xml 356 379 356 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans,</italic>
###xml 940 951 940 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila,</italic>
###xml 1130 1140 1130 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 1145 1156 1145 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila,</italic>
###xml 1468 1478 1468 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1525 1526 1525 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1527 1528 1527 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1529 1530 1529 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 356 378 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 1130 1140 <span type="species:ncbi:6239">C. elegans</span>
Dosage compensation, which ensures that the expression of X-linked genes is equal in males and females, is an essential process in organisms that have sex chromosomes. Because sex chromosomes appeared relatively late in evolution, dosage compensation evolved independently in different organisms and is accomplished by distinct mechanisms. For example, in Caenorhabditis elegans, dosage compensation occurs in the homogametic hermaphrodite (XX) by the down-regulation of virtually all genes on the two X chromosomes by about 50%. In mammals, dosage compensation also occurs in the homogametic sex (the female) by X inactivation, whereby an entire X chromosome forms a distinct, heterochromatic, transcriptionally inactive nuclear structure known as the Barr body. Consequently, each gene on the single active X chromosome in female cells and the corresponding gene on the single X chromosome in male cells are expressed at equal levels. In Drosophila, dosage compensation is achieved in the heterogametic male by a twofold chromosome-wide up-regulation (hypertranscription) of essentially all genes on the single X chromosome. In C. elegans and Drosophila, several proteins with different molecular functions involved in dosage compensation have been identified. Much attention has been dedicated to the elusive question of how the compensated or inactivated chromosomes are recognized by these proteins, and three recent papers investigating some of these aspects in Drosophila have provided new insights into this mystery [1,2,3].
###end p 3
###begin p 4
###xml 41 51 41 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xist</italic>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 361 372 361 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila,</italic>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xist</italic>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xist</italic>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
At least one common theme has emerged in Drosophila and mammals of how the dosage-compensated chromosomes are marked and eventually recognized by regulatory proteins: the use of non-coding RNAs transcribed from genes located on the X chromosome itself [4,5,6,7]. These RNAs, Xist (X-inactive specific transcript) in mammals, and roX1 and roX2 (RNA on the X) in Drosophila, are structurally unrelated, yet they share the intriguing property of remaining tightly associated with the X chromosome. In mammals, Xist RNA is transcribed only from the inactive X, with which it associates at its site of synthesis and then spreads over the entire chromosome through an unknown mechanism [8]. It is assumed that Xist RNA provides a mark for specific histones (for example, histone macroH2A1.2), as well as proteins deacetylating histones and methylating many of the X-linked genes at GpC dinucleotides [9,10,11]; all these events are important for maintaining the silenced state of the inactivated X.
###end p 4
###begin title 5
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
The Drosophila dosage compensation complex
###end title 5
###begin p 6
###xml 3 14 3 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila,</italic>
###xml 125 155 125 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">male-specific lethal-1, -2, -3</italic>
###xml 157 167 157 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msl1, msl2</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msl3</italic>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">maleless</italic>
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mle</italic>
###xml 198 223 198 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">males absent on the first</italic>
###xml 225 228 225 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mof</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msl</italic>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 890 893 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 904 907 904 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1018 1022 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 1026 1030 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 1058 1061 1058 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1195 1196 1195 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1332 1335 1332 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1496 1499 1496 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1563 1564 1563 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1565 1566 1565 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1567 1568 1567 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1614 1617 1614 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1694 1697 1694 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
In Drosophila, the dosage compensation complex (DCC) is composed of five proteins encoded by the male-specific lethal genes, male-specific lethal-1, -2, -3 (msl1, msl2 and msl3), maleless (mle) and males absent on the first (mof), and at least two non-coding RNAs, roX1 and roX2 (for a review see [12]). The MSL proteins colocalize to hundreds of sites along the single male X chromosome; they all are essential for the hypertranscription of the X-chromosomal genes in males, as male but not female animals die during development when they are mutant for any one of the five msl genes. Hypertranscription is a consequence of at least one chromatin modification: the acetylation of histone H4 at Lys16, which is thought to 'loosen' chromatin structure, thereby allowing the general transcription machinery easier access to the regulatory regions of most X-linked genes [13]. The role of the roX genes and roX RNAs in this process is still unclear. Localization studies of MSL proteins in male nuclei carrying autosomal roX1 or roX2 transgenes showed that the roX genes or RNAs recruit the entire set of MSL proteins to their transgenic location and can lead locally to acetylation of histone H4 [1,14]. Moreover, the DCCs can spread, by several hundred kilobases, into neighboring autosomal DNA. These experiments indicated that the roX genes might function as nuclear entry sites for the assembly of the MSL proteins on the X chromosome. Little was known, however, about the specific role of the roX RNAs during the formation of the DCC. The three recent papers [1,2,3] have now started to address the role of the roX genes in this process and investigated which MSL proteins interact with the roX RNAs.
###end p 6
###begin p 7
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">msl</italic>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
Meller et al. [1] took advantage of the fact that dosage compensation can be initiated and analyzed in females ectopically expressing the male-specific MSL2 protein. These females hypertranscribe their two X chromosomes and therefore die during development, but they can be rescued if any other msl mutation is present. It has been shown previously, using a similar strategy, that the DCC is assembled in an ordered sequence (Figure 1). For example, MSL1 and MSL2 are the first proteins to bind to the X chromosome; in the absence of all other MSL proteins they associate with about 35 sites, the so-called chromatin entry sites. MSL1 and MSL2 are interdependent, however: they require each other for binding [15]. MLE appears to be the next protein to join the growing DCC as it is found at reduced levels at some of these 35 sites when the remaining two proteins, MSL3 and MOF, are absent [16]. These latter two proteins require all the other MSL proteins to be present to enable them to associate with the X chromosome. Importantly, all MSLs are required to generate the normal DCC distribution to the hundreds of sites throughout the entire X chromosome.
###end p 7
###begin p 8
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 525 528 525 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 716 720 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
Meller et al. [1] have now analyzed and compared roX RNA and MSL protein distribution in females ectopically expressing MSL2 but lacking other MSL proteins. They found that roX1 and roX2 RNAs are associated with the X chromosome at different stages and sites during the assembly of the DCC. When the MLE protein, which encodes an RNA helicase, was absent, both roX RNAs were found only at their site of transcription but not in any other of the 35 entry sites where MSL1 and MSL2 were present, suggesting that neither of the roX RNAs can be integrated in a minimal MSL1-MSL2 complex. When MSL3 was absent in these females, however, roX2 but not roX1 RNA was found at the entry 35 sites. These findings indicate that roX2 might be incorporated into this partial DCC complex in an MLE-dependent manner and that roX1 RNA is incorporated at a later stage, together with MSL3 and perhaps MOF.
###end p 8
###begin p 9
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 176 186 176 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 257 263 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 396 402 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 605 611 605 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 705 709 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 1074 1081 1074 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1086 1095 1086 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro,</italic>
###xml 1114 1120 1114 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1236 1239 1236 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mof</italic>
###xml 1336 1341 1336 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2,</italic>
Further evidence that at least roX2 RNA is an integral part of the DCC comes from independent immunoprecipitation experiments from all three groups [1,2,3] using extracts from Drosophila S2 cells that express all the MSLs and roX2 RNA. Surprisingly, Akthar et al. [2] found that DCC lacking MLE but containing the remaining MSLs still precipitated roX2 RNA. The ordered assembly data from Meller et al. [1] as well as the fact that MLE is the only protein in the DCC featuring a known RNA-binding domain pointed towards the RNA helicase MLE as the primary candidate for a partner for the roX2 RNA. Akthar et al. [2] turned their focus towards the MOF protein as a potential candidate for interaction with roX2 RNA. MOF is the crucial component that links the DCC to the X-chromosome-specific acetylated form of histone H4. MOF encodes an 827 amino-acid protein containing an amino terminus of unknown function, a chromodomain, a zinc finger and a carboxy-terminal histone acetyltransferase (HAT) domain. The HAT domain of MOF is responsible for histone H4 acetylation, both in vivo and in vitro, as shown by Smith et al. [3]. Interestingly, immunoprecipitation assays using extracts from SL-2 cells transfected with wild-type or mutant mof genes indicated that the chromodomain is essential for the specific interaction between MOF and roX2, but that the amino-terminal region and HAT domain were not essential for this interaction.
###end p 9
###begin p 10
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1173 1183 1173 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1270 1276 1270 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1278 1279 1278 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 783 788 <span type="species:ncbi:4932">yeast</span>
Akthar et al. [2] then tested the putative RNA-binding property of MOF directly using electromobility shift assays. MOF appeared to bind to RNA rather non-specifically, but preferred RNA to DNA. In agreement with the immunoprecipitation results, they found that an intact chromodomain is essential for RNA binding, whereas the amino terminus or the HAT domain of MOF was not essential. Furthermore, they also showed that MSL3, which features two chromodomains on its own, also shows roX RNA binding properties. Although the specificity of these interactions remains to be investigated, the findings of Akthar and coworkers [2] provide a new possible role for chromodomains involved in RNA binding. Chromodomains are modules of about 50 amino acids found in a number of proteins from yeast to mammals; the function of these proteins vary, but they are most often associated with gene silencing and chromatin remodeling events; significantly, many chromodomain-containing proteins are associated on chromosomes with heterochromatin or heterochromatin-like regions (reviewed in [17]). The specific role of the chromodomain is unknown, but chromodomain swapping experiments in Drosophila suggest that they might be protein interaction modules [18]. Thus, the data by Akthar et al. [2] suggests a new and rather unexpected role for these modules in RNA binding. It is intriguing to speculate that the chromodomain of other remodeling proteins also exert their activity through RNA interactions and that RNAs might be more common than generally appreciated in transcriptional regulation.
###end p 10
###begin title 11
Multiple RNA-protein interactions within the DCC
###end title 11
###begin p 12
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 303 313 303 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 857 865 857 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo.</italic>
How can we reconcile the findings of Akthar et al. [2] and Meller et al. [1]? First, it might be relevant that the co-immunoprecipitations and the in vitro binding experiments were performed with SL-2 cell extracts, cells in which dosage compensation appears not to be necessary; SL-2 cells, like other Drosophila cell lines, can become aneuploid without reduced viability. The soluble DCCs from these extracts are therefore not necessarily functional and might differ from those in males. Second, the interaction between roX RNA and MOF protein appears to lack specificity. The lack of specificity might be attributed to a number of reasons, such as the absence of other MSL components, the presence of other RNAs interacting with MOF, or worse, it might reflect a property of MOF without functional significance: that is, MOF might not contact RNA at all in vivo.
###end p 12
###begin p 13
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 216 219 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1022 1026 1022 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 1170 1174 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 1420 1424 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 1530 1534 1530 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 1598 1602 1598 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
Keeping this cautious note in mind, a more attractive alternative could be envisioned. The main proposition of this model is that roX2 can interact with both MLE and MOF, and perhaps even other MSL proteins, as both roX RNAs are certainly large enough to accommodate binding sites for several proteins [6]. If such a scenario is correct, each of the interactions between different components of the DCC might be quite weak, and perhaps not even highly specific, but in the context of additional interactions becomes more stable. The addition of each new component might therefore strengthen existing interactions by optimizing contacts between binding surfaces through adjustments in the higher-order structure of the components (Figure 1). Evidence from co-immunoprecipitation experiments indicates that MSL1 and MSL2 interact directly with each other, a notion supported by the MSL1-MSL2 association at the 35 chromosomal entry sites in the absence of any other MSLs (the preDCC; Figure 1). The addition of both MLE and roX2 RNA might allow the formation of a primary complex (the primDCC), which might be stabilized by the direct interaction of a structural motif of roX2 RNA with the MLE protein, as well as interactions of this complex with MSL1 and MSL2. The primDCC might then be reinforced by the addition of the remaining two proteins, MSL3 and MOF, one or both of which might recognize other motifs within the roX2 RNA, to form the mature complex (matDCC). Finally, matDCC might be further stabilized by the addition of roX1 RNA, which could interact with several of the MSLs and perhaps roX2 RNA as well. Significantly, assembly and disassembly of the complex might not necessarily follow the same order. For example, once the complex is formed, removal (for example, by high ionic strength) of a single component brought in relatively early (such as MLE) might be possible without affecting the rest of the complex.
###end p 13
###begin p 14
###xml 134 137 134 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 188 196 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 571 574 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2,</italic>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 907 911 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 1016 1019 1016 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1025 1033 1025 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo.</italic>
###xml 1047 1051 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 1056 1060 1056 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 1285 1288 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1597 1600 1597 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 1739 1740 1739 1740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 413 418 <span type="species:ncbi:4932">yeast</span>
One major task at hand now will be to resolve the specificities of the proposed interactions between the various MSL proteins and the roX RNAs. This could be done by carrying out detailed in vitro studies, which might not be easy to perform; many MSL proteins are difficult to express stably in bacteria or eukaryotic expression systems. An alternative might be to establish a heterologous in vivo system such as yeast, where protein-protein and RNA-protein interactions can be readily detected using sensitive reporter assays. A second important question is whether the roX genes have the same, overlapping or complementing functions. Although roX1 mutant males are fully viable [7], it was suggested that roX1 mutant males lacking a large number of additional genes, including roX2, have a lethal dosage-compensation phenotype because the DCC fails to assemble on the X chromosome [19]. Unfortunately, no roX2 mutations have been recovered yet; they would be important tools for validating the significance of the roX RNAs in vivo. Furthermore, roX1 and roX2 are only the first two of about 35 chromatin entry sites, although perhaps they are the most important ones. The nature of the remaining 33 sites is entirely unclear and there is, as yet, no evidence that they contain other roX-like RNAs. This brings us to the largest of all mysteries, namely how the DCC is spread along the X chromosome. One possibility is that the remaining 33 or so sites are 'stations' that serve as spreading facilitators in the form of DNA elements. Thus, primDCCs and/or mature (mat) DCCs, originating from the roX entry sites, might hop from one 'station' to the next and eventually reach all the entry sites distributed along the entire X chromosome [1]. From these sites, they then reach into the neighboring chromatin regions by yet another mechanism.
###end p 14
###begin p 15
###xml 56 66 56 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 371 382 371 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila,</italic>
###xml 402 412 402 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CroX</italic>
###xml 633 647 633 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans roX</italic>
###xml 56 66 <span type="species:ncbi:6239">C. elegans</span>
###xml 402 412 <span type="species:ncbi:6239">C. elegans</span>
###xml 633 643 <span type="species:ncbi:6239">C. elegans</span>
One final thought: the dosage compensation machinery in C. elegans acts on the two X chromosomes in the hermaphrodite by twofold down-regulation of gene expression. Six proteins are essential for this process and they associate with the X chromosomes; four of them are related to factors involved in chromosome condensation during mitosis in other systems. Not unlike in Drosophila, the DCC complex of C. elegans is also assembled in an ordered sequence, but no RNAs have been identified that might be involved in this assembly process [20]; either there will be yet another surprising turn in this multifaceted process or the CroX (C. elegans roX) RNAs wait to be discovered.
###end p 15
###begin title 16
Acknowledgements
###end title 16
###begin p 17
I thank Joe Nevins and Raquel Sitcheran for critically reading the manuscript. The author is supported by a Grant from N.I.H. (GM60234-01).
###end p 17
###begin article-title 18
###xml 90 101 90 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila.</italic>
Ordered assembly of roX RNAs into MSL complexes on the dosage-compensated X chromosome in Drosophila.
###end article-title 18
###begin article-title 19
Chromodomains are protein-RNA interaction modules.
###end article-title 19
###begin article-title 20
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
The Drosophila MSL complex acetylates histone H4 at lysine 16, a chromosome modification linked to dosage compensation.
###end article-title 20
###begin article-title 21
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus.
###end article-title 21
###begin article-title 22
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus.
###end article-title 22
###begin article-title 23
###xml 41 51 41 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Genes expressed in neurons of adult male Drosophila.
###end article-title 23
###begin article-title 24
###xml 41 51 41 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
roX1 RNA paints the X chromosome of male Drosophila and is regulated by the dosage compensation system.
###end article-title 24
###begin article-title 25
XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure.
###end article-title 25
###begin article-title 26
Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals.
###end article-title 26
###begin article-title 27
The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression.
###end article-title 27
###begin article-title 28
###xml 73 78 <span type="species:ncbi:9606">human</span>
Reduced levels of histone H3 acetylation on the inactive X chromosome in human females.
###end article-title 28
###begin article-title 29
Dosage compensation in flies and worms: the ups and downs of X-chromosome regulation.
###end article-title 29
###begin article-title 30
###xml 114 124 114 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Histone H4 isoforms acetylated at specific lysine residues define individual chromosomes and chromatin domains in Drosophila polytene nuclei.
###end article-title 30
###begin article-title 31
###xml 28 38 28 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Epigenetic spreading of the Drosophila dosage compensation complex from roX RNA genes into flanking chromatin.
###end article-title 31
###begin article-title 32
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
Drosophila male-specific lethal-2 protein: structure/function analysis and dependence on MSL-1 for chromosome association.
###end article-title 32
###begin article-title 33
###xml 80 103 80 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 80 103 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Targeting of MOF, a putative histone acetyl transferase, to the X chromosome of Drosophila melanogaster.
###end article-title 33
###begin article-title 34
Mammalian chromodomain proteins: their role in genome organisation and expression.
###end article-title 34
###begin article-title 35
Functional analysis of the chromo domain of HP1.
###end article-title 35
###begin article-title 36
###xml 107 117 107 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
The roX1 and roX2 RNAs are essential components of the compensasome, which mediates dosage compensation in Drosophila.
###end article-title 36
###begin article-title 37
Sex in the worm:counting and compensating X-chromosome dose.
###end article-title 37
###begin title 38
Figures and Tables
###end title 38
###begin p 39
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX</italic>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
###xml 742 750 742 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 893 897 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 996 1000 996 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 1068 1072 1068 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX1</italic>
###xml 1077 1081 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">roX2</italic>
Ordered assembly of MSL proteins and roX RNA increases stability of the DCC. The first step of assembly involves the recognition of about 35 chromosomal entry sites by a preDCC consisting of MSL1 and MSL2. This recognition does not require any of the known roX RNAs. In the next step, roX2 and MLE enter the complex to form a more stable primary DCC (PrimDCC) at these 35 sites. Spreading throughout the entire X chromosome requires the formation of the complete complex by addition of MOF and MSL3. The sequential addition of new components, particularly the roX2 RNA, might induce changes in the structure of already incorporated components (illustrated by ovals becoming circles), increasing the stability of the DCC. MLE might be removed in vitro (for example, by elevated ionic strength) without destroying the entire complex, because of the stabilizing presence of MOF-MSL3. The role of roX1 RNA is not clear, but it is integrated late in this process, together with or after MOF and MSL3; roX1 might provide additional stability to the mature DCC (MatDCC). So, roX1 and roX2 might be partially redundant.
###end p 39

